Artificial Embolization Device Downclassification Supported By Panel
This article was originally published in The Gray Sheet
Executive Summary
Artificial embolization devices for neurological use should be downclassified to Class II, FDA's Neurological Devices Panel agreed at a June 12 meeting in Rockville, Maryland.
You may also be interested in...
Neurovascular, Vascular Embolization Devices Shifting To Class II
FDA is adding vascular devices to its proposed recategorization of neurovascular embolization devices from Class III to Class II with special controls
Neurovascular, Vascular Embolization Devices Shifting To Class II
FDA is adding vascular devices to its proposed recategorization of neurovascular embolization devices from Class III to Class II with special controls
MCAC Device Panel Chairman Sees Opportunity To Raise Clinical Standards
The Medicare Coverage Advisory Committee should demand the same standards of evidence as other established technology assessment programs, Medical Device and Prosthetics Panel Chairman Harold Sox, MD, Dartmouth-Hitchcock Medical Center maintains.